Clinical trial
Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While…
NCT00007670 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00007670 |
|---|---|
| Title | Does Gabapentin and Lamotriginel Have Significantly Fewer Side-effects While Providing Equal or Better Seizure Control Than the Current Drug Choice, Carbamazepine, for the Treatment of Seizures in the Elderly. |
| Official title | CSP #428 - Treatment of Seizures in the Elderly Population |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Parke-Davis Industry Glaxo Wellcome |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seizures |
| Intervention type | Drug |
| Interventions | Carbamazepine, Gabapentin, Lamotrigine |
| Enrollment | 720 |
| Start date | Jan 1, 1998 |
| Completion | Mar 1, 2003 |
| First posted | Jan 4, 2001 |
| Last update posted | Oct 30, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: